As a Free StocksGuide user, you can view scores for all 7,040 stocks worldwide.
24 Analysts have issued a QIAGEN NV forecast:
24 Analysts have issued a QIAGEN NV forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 2,040 2,040 |
5%
5%
|
|
| Gross Profit | 1,309 1,309 |
7%
7%
|
|
| EBITDA | 556 556 |
21%
21%
|
|
| EBIT (Operating Income) EBIT | 548 548 |
22%
22%
|
|
| Net Profit | 373 373 |
414%
414%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
| Head office | Netherlands |
| CEO | Thierry Bernard |
| Employees | 5,232 |
| Founded | 1996 |
| Website | www.qiagen.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


